SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
MEDX 31.18-0.3%Oct 29 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (2194)7/8/2009 3:27:56 PM
From: nigel bates  Read Replies (1) of 2240
 
>>It is the indication (and result) that matters<<

I appreciate that.

My point was that shareholders sold ABGX for a couple of billion three years ago, and in one morning it has added $9bn to AMGN's value.

Plenty of 'indications' in the MEDX pipeline. Of course, the 'results' are moot - but then again, I'm not claiming it's worth $9bn.
Just that the denosumab news provides a little perspective.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext